Skip to main content

Advocacy Groups and Their Role in Rare Diseases Research

  • Chapter
  • First Online:
Rare Diseases Epidemiology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 686))


One of the remarkable and unique aspects of the recent history of rare disease research has been the evolving role of patient advocacy groups and the collaborative partnership that exists among such groups and the scientists who study rare diseases, as well as the government officials charged with overseeing medical research and regulatory processes. This collaboration, which in many respects developed out of necessity on all sides, is unparalleled in other areas of medical research and product development. It has played a significant role over the past 30 years in the adoption of public policies, available research funding and other factors affecting the general climate for research on rare diseases. Specific areas of interest include the adoption of the Orphan Drug Act in the U.S. in 1983 and subsequent similar legislation elsewhere in the world; the relationship of patient advocacy groups with government research funding and regulatory entities; the role of patient advocacy groups in seeking to “de-risk” orphan product development through initiatives such as facilitating patient registries and disease natural histories; the role of advocacy groups in ensuring that patients have access to treatments; and the increasing globalization of patient advocacy initiatives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others


  1. Asbury CH (1985) Orphan drugs: medical vs. market value. Heath and Company, Lexington, MA

    Google Scholar 

  2. Haffner ME (2006) Adopting orphan drugs: two dozen years of treating rare diseases. NEJM 354:445–47

    Article  PubMed  CAS  Google Scholar 

  3. Waxman H (2009) The Waxman report: how congress really works. Grand Central Publishing, New York, NY

    Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Mary Dunkle .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Netherlands

About this chapter

Cite this chapter

Dunkle, M., Pines, W., Saltonstall, P.L. (2010). Advocacy Groups and Their Role in Rare Diseases Research. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht.

Download citation

Publish with us

Policies and ethics